Pharmacoepidemiological Study (Drug Utilization Study) of JAYDESS Use in Routine Clinical Practice in Sweden
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 31 Jan 2018
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Bayer
- 26 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 08 Mar 2017 Planned End Date changed from 1 Dec 2022 to 31 Dec 2022.
- 08 Mar 2017 Planned primary completion date changed from 1 Dec 2022 to 31 Dec 2022.